Business Description
![InMed Pharmaceuticals Inc InMed Pharmaceuticals Inc logo](https://static.gurufocus.com/logos/0C00000FVT.png?14)
InMed Pharmaceuticals Inc
NAICS : 325411
SIC : 3741
ISIN : CA4576371062
Description
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 7.1 | |||||
Equity-to-Asset | 0.83 | |||||
Debt-to-Equity | 0.1 | |||||
Debt-to-EBITDA | -0.18 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -10.92 | |||||
Beneish M-Score | -1.83 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 57.8 | |||||
3-Year EPS without NRI Growth Rate | 57.8 | |||||
3-Year FCF Growth Rate | 55.9 | |||||
3-Year Book Growth Rate | -49.5 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 42.45 | |||||
9-Day RSI | 45.88 | |||||
14-Day RSI | 46.28 | |||||
6-1 Month Momentum % | -19.94 | |||||
12-1 Month Momentum % | -69.03 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.58 | |||||
Quick Ratio | 5.8 | |||||
Cash Ratio | 4.97 | |||||
Days Inventory | 128.38 | |||||
Days Sales Outstanding | 15.27 | |||||
Days Payable | 50.58 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -151.7 | |||||
Shareholder Yield % | -258.24 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 39.18 | |||||
Operating Margin % | -118.04 | |||||
Net Margin % | -108 | |||||
FCF Margin % | -117.79 | |||||
ROE % | -52.44 | |||||
ROA % | -44.44 | |||||
ROIC % | -156.72 | |||||
ROC (Joel Greenblatt) % | -373.93 | |||||
ROCE % | -55.76 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.21 | |||||
PB Ratio | 0.15 | |||||
Price-to-Tangible-Book | 0.18 | |||||
EV-to-EBIT | 0.63 | |||||
EV-to-EBITDA | 0.69 | |||||
EV-to-Revenue | -0.74 | |||||
EV-to-Forward-Revenue | 0.01 | |||||
EV-to-FCF | 0.63 | |||||
Price-to-Net-Current-Asset-Value | 0.21 | |||||
Price-to-Net-Cash | 0.31 | |||||
Earnings Yield (Greenblatt) % | 158.73 | |||||
FCF Yield % | -281.93 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
InMed Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 5.194 | ||
EPS (TTM) (€) | -0.794 | ||
Beta | -0.23 | ||
Volatility % | 55.51 | ||
14-Day RSI | 46.28 | ||
14-Day ATR (€) | 0.015586 | ||
20-Day SMA (€) | 0.226555 | ||
12-1 Month Momentum % | -69.03 | ||
52-Week Range (€) | 0.1974 - 1.696 | ||
Shares Outstanding (Mil) | 8.92 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
InMed Pharmaceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
InMed Pharmaceuticals Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
InMed Pharmaceuticals Inc Frequently Asked Questions
What is InMed Pharmaceuticals Inc(STU:MWG0)'s stock price today?
The current price of STU:MWG0 is €0.23. The 52 week high of STU:MWG0 is €1.70 and 52 week low is €0.20.
When is next earnings date of InMed Pharmaceuticals Inc(STU:MWG0)?
The next earnings date of InMed Pharmaceuticals Inc(STU:MWG0) is 2024-08-15 Est..
Does InMed Pharmaceuticals Inc(STU:MWG0) pay dividends? If so, how much?
InMed Pharmaceuticals Inc(STU:MWG0) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |